Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Lymphoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 7Leukemia 7Hodgkin Disease 6Leukemia, Lymphocytic, Chronic, B-Cell 5Multiple Myeloma 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Sarcoma 3Neoplasms 2Myelodysplastic Syndromes 2Fatigue 2Weight Loss 1Vaginal Neoplasms 1Uterine Neoplasms 1Thyroid Neoplasms 1Thrombocytopenia 1Splenomegaly 1Sleep Initiation and Maintenance Disorders 1Sezary Syndrome 1Pyloric Stenosis, Hypertrophic 1Patient Participation 1Ovarian Cysts 1Osteosarcoma 1Osteonecrosis 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1

Interventions

Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Splenomegaly × Surveys and Questionnaires × Lymphoid × Clear all
NCT02948283 2021-02-12

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

City of Hope Medical Center

Phase 1 Completed
3 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Lymphadenopathy, Anemia, Fatigue, Fever, Lymphocytosis, Multiple Myeloma, Splenomegaly, Thrombocytopenia, Weight Loss, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡